Literature DB >> 10966200

Dysplastic nodules and hepatocellular carcinoma: sensitivity of digital subtraction hepatic arteriography with whole liver explant correlation.

G A Krinsky1, M T Nguyen, V S Lee, R J Rosen, A Goldenberg, N D Theise, G Morgan, N M Rofsky.   

Abstract

PURPOSE: The purpose of this work was to determine the sensitivity of hepatic digital subtraction arteriography (DSA) for the detection of hepatocellular carcinoma (HCC) and dysplastic nodules (DNs) when compared with pathological findings from whole liver explants.
METHOD: Twenty-one patients 30-72 years old (mean 54 years) with cirrhosis and known or clinically suspected HCC (20 prior to chemoembolization) underwent hepatic DSA with subsequent transplantation within 80 days (mean 32 days). The prospective DSA report was compared with pathologic findings from explanted livers.
RESULTS: Overall, DSA detected 31 of 95 HCC lesions for a sensitivity of 33%. Of these 31 lesions, 28 were hypervascular and 3 were hypovascular. DSA detected all six HCCs measuring >5 cm, all six HCCs measuring 3-5 cm, and all five HCCs 2-3 cm, resulting in a sensitivity of 100% (17/17) for HCC >2 cm. DSA detected 7 of 18 HCCs measuring 1-2 cm (sensitivity 39%) and 7 of 60 HCCs < or =1 cm (sensitivity 12%). Overall sensitivity for DSA in detection of HCC < or =2 cm was 18% (14/78 lesions). None of 17 DNs (0.2-1.5 cm in size) was identified on DSA.
CONCLUSION: DSA is insensitive to small HCC (< or =2 cm), carcinomatosis arising within nodules, and DN.

Entities:  

Mesh:

Year:  2000        PMID: 10966200     DOI: 10.1097/00004728-200007000-00022

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

1.  An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features.

Authors:  Xin Li; Chuan-Sheng Zheng; Gan-Sheng Feng; Chen-Kai Zhuo; Jun-Gong Zhao; Xi Liu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

2.  Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.

Authors:  Kellie Young; Nicholas Fidelman; Francis Y Yao; Nancy K Hills; Maureen P Kohi; K Pallav Kolli; Andrew G Taylor; Robert K Kerlan
Journal:  Liver Transpl       Date:  2015-04       Impact factor: 5.799

3.  MRI features of intrahepatic extramedullary haematopoiesis in sickle cell anaemia.

Authors:  Mohamed Ali Jelali; Alain Luciani; Hicham Kobeiter; Serge Zafrani; Marie Christine Anglade; Benhalima Zegai; Dora Bachir; Alain Rahmouni
Journal:  Cancer Imaging       Date:  2006-11-28       Impact factor: 3.909

4.  Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.

Authors:  Lauren M Ladd; Temel Tirkes; Mark Tann; David M Agarwal; Matthew S Johnson; Bilal Tahir; Kumaresan Sandrasegaran
Journal:  Clin Mol Hepatol       Date:  2016-12-14

5.  Digital subtract angiography and lipiodol deposits following embolization in cirrhotic nodules of LIRADS category ≥3.

Authors:  Zhen Kang; Nan Wang; Anhui Xu; Liang Wang
Journal:  Eur J Radiol Open       Date:  2019-02-23

6.  Hepatocellular carcinoma - issues in imaging.

Authors:  C H Thng; Y T Kuo
Journal:  Cancer Imaging       Date:  2004-10-20       Impact factor: 3.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.